Platinum Industries Adjusts Valuation Grade Amid Strong Financial Metrics and Market Position
Platinum Industries, a small-cap chemicals company, has adjusted its valuation metrics, with a price-to-earnings ratio of 28.22 and a price-to-book value of 4.20. The firm demonstrates strong performance with a return on capital employed of 32.11% and a competitive edge over peers in the market.
Platinum Industries, a small-cap player in the chemicals sector, has recently undergone a valuation adjustment, reflecting its current financial metrics and market position. The company's price-to-earnings ratio stands at 28.22, while its price-to-book value is noted at 4.20. Additionally, the enterprise value to EBITDA ratio is recorded at 20.93, indicating a robust valuation relative to its earnings before interest, taxes, depreciation, and amortization.In terms of performance, Platinum Industries showcases a return on capital employed (ROCE) of 32.11% and a return on equity (ROE) of 14.46%, suggesting effective utilization of capital and shareholder equity. The company's recent stock performance has shown a weekly return of 0.42% and a monthly return of 7.84%, contrasting with the Sensex's performance during the same periods.
When compared to its peers, Platinum Industries maintains a competitive edge, particularly in its valuation metrics. For instance, while Neogen Chemicals also holds a high valuation, its price-to-earnings ratio significantly exceeds that of Platinum. Other competitors like Gujarat Alkalies are currently facing challenges, being categorized as loss-making, which further highlights Platinum's relative strength in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
